06 Nov MYC targeting by Omomyc enhances the efficacy and overcomes resistance to the KRAS inhibitor Sotorasib in NSCLC

Posted at 15:14h in SIGNALING AND EPIGENETICS IN CANCER by

ID: 03271

Authors: Capitán, Daniel (1); González, Íñigo (1); Sansegundo, Lorena (2); Casacuberta, Sílvia (2); Soucek, Laura (1,2,3,4)

Topic: SIGNALING AND EPIGENETICS IN CANCER